Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
Table 1
Radiation dosing.
Patient #
Age at initial treatment (yr)
Prostate cancer risk strata@
ADT with BRT #1
ADT with BRT #2
Initial dose
Time b/w Rx (mo)
Salvage dose
Volume treated (cc)
1≠
57
Low
No
No
115 Gy
38
144 Gy
21.55
2
61
Low
No
No
144 Gy
32
144 Gy
13.23
3
65
Low
No
Yes
144 Gy
26
144 Gy
7.56
4
63
Intermediate
No
No
144 Gy
34
144 Gy
9.98
5
59
Low
No
No
144 Gy
26
108 Gy
21.58
6≠
50
Low
No
Yes
115 Gy
67
108 Gy
26.66
7
48
x
No
No
x
287
108 Gy
21.31
8
60
Low
No
No
144 Gy
123
108 Gy
6.84
9
55
Low
Yes
No
144 Gy
120
108 Gy
7.76
10
57
Low
No
No
144 Gy
19
120 Gy
23.78
11
48
Low
Yes
No
144 Gy
25
125 Gy
16.03
12
66
Low
No
No
144 Gy
46
108 Gy
18.16
13
44
Low
No
No
144 Gy
31
144 Gy
12.05
14
50
Intermediate
No
No
144 Gy
87
144 Gy
15.51
15
66
Intermediate
Yes
No
108 Gy
42
108 Gy
8.1
16
71
Intermediate
No
No
144 Gy
45
108 Gy
29.36
17
63
Intermediate
No
Yes
108 Gy
48
108 Gy
9.74
18
42
x
Yes
No
x
50
120 Gy
12.94
19
58
Intermediate
Yes
No
108 Gy
105
108 Gy
8.67
20
59
Low
Yes
No
144 Gy
48
144 Gy
27.31
21
72
Low
Yes
No
140 Gy
21
140 Gy
19.93
Patients who underwent initial external beam radiation therapy. Patients who underwent initial open brachytherapy. ≠Patients who had palladium-103 seeds for initial brachytherapy. x = data point not known. ADT = androgen deprivation therapy; BRT = brachytherapy. @ = D’amico risk strata [10].
